[Plasma cortisol level, hematocrit and hemoglobin value as well as erythrocyte count and differential blood picture in twice-daily budesonide inhalation therapy].
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy*; D019819:Budesonide; D002908:Chronic Disease; D004906:Erythrocyte Count; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D011282:Pregnenediones / Q000009:adverse effects* / Q000627:therapeutic use; D012138:Respiratory Therapy
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; D019819:Budesonide; D006854:Hydrocortisone
Plasmakortisolspiegel, Hämatokrit- und Hämoglobin-Wert sowie Erythrozytenzahlen und Differentialblutbild unter einer 2x täglichen inhalativen Budesonid-Therapie.